Hasubanonine, O4-demethyl- | 24148-86-5

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈苏巴南生物碱
• 英文名称: Hasubanonine, O4-demethyl-
• 英文别名: 3-hydroxy-4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one
• CAS: 24148-86-5
• 化学式: C₂₀H₂₅NO₅
• 分子量: 359.4
• InChiKey: XLWYWPDYNLZUJS-UHFFFAOYSA-N

物化性质

• 熔点：
  70 °C
• 沸点：
  565.2±50.0 °C(Predicted)
• 密度：
  1.30±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  68.2
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN AND DEPENDANCE DISORDERS<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA DOULEUR ET DE TROUBLES DE LA DÉPENDANCE
  申请人：RIPPLE THERAPEUTICS CORP

  公开号：WO2021024039A1

  公开（公告）日：2021-02-11

  Provided herein are (e.g., controlled release) compositions for the treatment of acute or chronic diseases or disorders. Described herein are processable opioid conjugates. Also described herein are compositions and methods for the treatment of central nervous system (CNS) diseases or disorders including chronic pain (e.g., cancer pain), acute pain, opioid addiction, alcohol addiction, alcohol dependence, opioid-induced constipation, and narcotic depression. Said compositions and methods comprise opioid agonists and/or opioid antagonists, which demonstrate CNS activity and/or other desirable activities. Injection of said compositions subcutaneously or intraspinally provides therapeutic benefit to individuals suffering from CNS diseases or disorders

  本文提供了用于治疗急性或慢性疾病或障碍的（例如，控释）组合物。本文描述了可加工的阿片类结合物。本文还描述了用于治疗中枢神经系统（CNS）疾病或障碍的组合物和方法，包括慢性疼痛（例如，癌症疼痛）、急性疼痛、阿片类成瘾、酒精成瘾、酒精依赖、阿片类引起的便秘和麻醉性抑郁症。所述组合物和方法包括表现出CNS活性和/或其他理想活性的阿片类激动剂和/或阿片类拮抗剂。将所述组合物皮下或脊髓内注射可为患有中枢神经系统疾病或障碍的个体提供治疗益处。
• NF-kB activity inhibitor
  申请人：Kaken Shoyaku Co., Ltd.

  公开号：EP0931544A2

  公开（公告）日：1999-07-28

  This invention relates to an NF-κB activity inhibitor which contains alkaloids originated from a plant belonging to the genus Stephania of the family Menspermaceae, derivatives thereof and salts thereof, as the active components, to an agent for use in the treatment and prevention of diseases upon which the NF-κB activity inhibiting action is effective and to an inhibitor of the expression of related genes. Since said active components exert an action to inhibit transcription of DNA having an NF-κB recognition sequence by inhibiting the activity of NF-κB, the drug of the present invention can inhibit expression of genes of certain substances such as cytokines, inflammatory cytokine receptor antagonists, MHC class I, MHC class II, β2 microglobulin, immunoglobulin light chain, serum amyloid A, angiotensinogen, complement B, complement C4, C-myc gene, HIV, SV40, CMV, adenovirus and the like, so that the inventive drug is useful in treating and/or preventing various diseases in which these substances are taking roles.

  本发明涉及一种NF-κB活性抑制剂，其活性成分含有源自一种属于孟婆子科斯蒂芬尼亚属植物的生物碱、其衍生物及其盐类，涉及一种用于治疗和预防NF-κB活性抑制作用有效的疾病的药物，还涉及一种相关基因表达抑制剂。MHCⅠ类、MHCⅡ类、β2微球蛋白、免疫球蛋白轻链、血清淀粉样蛋白A、血管紧张素原、补体B、补体C4、C-myc基因、HIV、SV40、CMV、腺病毒等，因此本发明药物可用于治疗和/或预防这些物质起作用的各种疾病。
• METHODS AND DEVICES FOR COMPOUND DELIVERY
  申请人：E-Nicotine Technology, Inc.

  公开号：EP2925395A1

  公开（公告）日：2015-10-07
• METHODS AND COMPOSITIONS FOR TREATING WITHDRAWAL SYNDROMES USING NON-SEDATIVE DEXMEDETOMIDINE TRANSDERMAL COMPOSITIONS
  申请人：Teikoku Pharma USA, Inc.

  公开号：EP3054934A1

  公开（公告）日：2016-08-17
• METHODS AND DEVICES FOR SMOKING URGE RELIEF
  申请人：Fontem Holdings 1 B.V.

  公开号：EP3096636A1

  公开（公告）日：2016-11-30